Impairment of mineralization by metavanadate and decavanadate solutions in a fish bone-derived cell line

Cell Biology and Toxicology

Volumn 24, Issue 3, 2008, Pages 253-263

  Tiago, Daniel M ^a   Laizé, Vincent ^a   Cancela, M Leonor ^a   Aureliano, Manuel ^a  

^a UNIVERSITY OF ALGARVE   (Portugal)

Author keywords

Bone derived cell line; Decavanadate; Insulin mimetic properties; Teleost fish Sparus aurata; Vanadate; Vertebrate bone formation

Indexed keywords

INSULIN; MONOMER; PROTEIN; VANADIC ACID;

ANIMAL EXPERIMENT; ARTICLE; BONE CELL; BONE DEMINERALIZATION; CELL LINE; CELL PROLIFERATION; CELL STIMULATION; EXTRACELLULAR MATRIX; FISH; INCUBATION TIME; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL;

ANIMALS; BONE AND BONES; CALCIFICATION, PHYSIOLOGIC; CELL LINE; CELL PROLIFERATION; EXTRACELLULAR MATRIX; FISHES; VANADATES;

MAMMALIA; SPARUS AURATA; TELEOSTEI; VERTEBRATA;

EID: 42549166545     PISSN: 07422091     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10565-007-9034-x     Document Type: Article

References (46)

1. Amado AM, Aureliano M, Ribeiro-Claro PJA, Teixeira-Dias JJ. Combined Raman and V-51 NMR spectroscopic study of vanadium (V) oligomerization in aqueous alkaline-solutions. J Raman Spectrosc 1993;24:699-703.
2. Anke M. Vanadium - An element both essential and toxic to plants, animals and humans? Anal Real Acad Nac Farm 2004;70:961-99.
3. Aureliano M, Madeira VM. Interactions of vanadate oligomers with sarcoplasmic reticulum Ca(2+)-ATPase. Biochim Biophys Acta 1994;1221:259-71.
4. Aureliano M, Gandara RM. Decavanadate effects in biological systems. J Inorg Biochem 2005;99:979-85.
5. Aureliano M, Joaquim N, Sousa A, Martins H, Coucelo JM. Oxidative stress in toadfish (Halobactrachus didactylus) cardiac muscle. Acute exposure to vanadate oligomers. J Inorg Biochem 2002;90:159-65.
6. Barrio DA, Etcheverry SB. Vanadium and bone development: putative signaling pathways. Can J Physiol Pharmacol 2006;84:677-86.
7. Barrio DA, Braziunas MD, Etcheverry SB, Cortizo AM. Maltol complexes of vanadium (IV) and (V) regulate in vitro alkaline phosphatase activity and osteoblast-like cell growth. J Trace Elem Med Biol 1997;11:110-5.
8. Bracken WM, Sharma RP, Elsner YY. Vanadium accumulation and subcellular distribution in relation to vanadate induced cytotoxicity in vitro. Cell Biol Toxicol 1985;1:259-68.
9. Canalis E. Effect of sodium vanadate on deoxyribonucleic acid and protein synthesis in culture rat calvariae. Endocrinology 1985a;116:855-62.
10. Canalis E. Effect of sodium vanadate on deoxyribonucleic acid and protein syntheses in cultured rat calvariae. Endocrinology 1985b;116:855-62.
11. Cheatham B, Kahn CR. Insulin action and the insulin signaling network. Endocr Rev 1995;16:117-42.
12. Cohick WS, Clemmons DR. The insulin-like growth factors. Annu Rev Physiol 1993;55:131-53.
13. Cortizo AM, Etcheverry SB. Vanadium derivatives act as growth factor-mimetic compounds upon differentiation and proliferation of osteoblast-like UMR106 cells. Mol Cell Biochem 1995;145:97-102.
14. Cortizo AM, Bruzzone L, Molinuevo S, Etcheverry SB. A possible role of oxidative stress in the vanadium-induced cytotoxicity in the MC3T3E1 osteoblast and UMR106 osteosarcoma cell lines. Toxicology 2000;147:89-99.
15. Cortizo AM, Molinuevo MS, Barrio DA, Bruzzone L. Osteogenic activity of vanadyl(IV)-ascorbate complex: evaluation of its mechanism of action. Int J Biochem Cell Biol 2006;38:1171-80.
16. Crans DC, Smee JJ, Gaidamauskas E, Yang L. The chemistry and biochemistry of vanadium and the biological activities exerted by vanadium compounds. Chem Rev 2004;104:849-902.
17. Dubyak GR, Kleinzeller A. The insulin-mimetic effects of vanadate in isolated rat adipocytes. Dissociation from effects of vanadate as a (Na+-K+) ATPase inhibitor. J Biol Chem 1980;255:5306-12.
18. Etcheverry SB, Cortizo AM. Bioactivity of vanadium compounds on cells in culture. In: Nriagu JO, editor. Vanadium in the environment. New York: John Wiley & Sons; 1998.
19. Etcheverry SB, Apella MC, Baran EJ. A model study of the incorporation of vanadium in bone. J Inorg Biochem 1984;20:269-74.
20. Etcheverry SB, Crans DC, Keramidas AD, Cortizo AM. Insulin-mimetic action of vanadium compounds on osteoblast-like cells in culture. Arch Biochem Biophys 1997;338:7-14.
21. Goldwaser I, Gefel D, Gershonov E, Fridkin M, Shechter Y. Insulin-like effects of vanadium: basic and clinical implications. J Inorg Biochem 2000;80:21-5.
22. Heyliger CE, Tahiliani AG, McNeill JH. Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats. Science 1985;227:1474-7.
23. Kato Y, Iwamoto M, Koike T, Suzuki F. Effect of vanadate on cartilagematrix proteoglycan synthesis in rabbit costal chondrocyte cultures. J Cell Biol 1987;104:311-9.
24. Kono SJ, Oshima Y, Hoshi K, Bonewald LF, Oda H, Nakamura K, et al. Erk pathways negatively regulate matrix mineralization. Bone 2007;40:68-74.
25. Lau KH, Tanimoto H, Baylink DJ. Vanadate stimulates bone cell proliferation and bone collagen synthesis in vitro. Endocrinology 1988;123:2858-67.
26. LeRoith D. Insulin-like growth factor I receptor signaling-overlapping or redundant pathways? Endocrinology 2000;141:1287-8.
27. Malich G, Markovic B, Winder C. The sensitivity and specificity of the MTS tetrazolium assay for detecting the in vitro cytotoxicity of 20 chemicals using human cell lines. Toxicology 1997;124:179-92.
28. McCarthy TL, Ji C, Centrella M. Links among growth factors, hormones, and nuclear factors with essential roles in bone formation. Crit Rev Oral Biol Med 2000;11:409-22.
29. Meyerovitch J, Farfel Z, Sack J, Shechter Y. Oral administration of vanadate normalizes blood glucose levels in streptozotocin-treated rats. Characterization and mode of action. J Biol Chem 1987;262:6658-62.
30. Moriyama S, Ayson FG, Kawauchi H. Growth regulation by insulin-like growth factor-I in fish. Biosci Biotechnol Biochem 2000;64:1553-62.
31. Murshed M, Harmey D, Millan JL, McKee MD, Karsenty G. Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes Dev 2005;19:1093-104.
32. Nielsen FH, Uthus EO. The essentiality and metabolism of vanadium. In: Chasteen ND, editor. Vanadium in biological systems. Boston: Kluwer Academic Publishers; 1990.
33. Pombinho AR, Laize V, Molha DM, Marques SM, Cancela ML. Development of two bone-derived cell lines from the marine teleost Sparus aurata; evidence for extracellular matrix mineralization and cell-type-specific expression of matrix Gla protein and osteocalcin. Cell Tissue Res 2004;315:393-406.
34. Quarto R, Campanile G, Cancedda R, Dozin B. Thyroid hormone, insulin and glucocorticoids are sufficient to support chondrocyte differentiation to hypertrophy: a serum-free analysis. J Cell Biol 1992;119:989-95.
35. Rehder D. The coordination chemistry of vanadium as related to its biological functions. Coord Chem Rev 1999;182:297-322.
36. Rehder D. Biological and medicinal aspects of vanadium. Inorg Chem Commun 2003;6:604-17.
37. Salice VC, Cortizo AM, Gomez Dumm CL, Etcheverry SB. Tyrosine phosphorylation and morphological transformation induced by four vanadium compounds on MC3T3E1 cells. Mol Cell Biochem 1999;198:119-28.
38. Shechter Y. Perspective in diabetes: insulin-mimetic effects of vanadate. Possible implications for future treatment of diabetes. Diabetes 1990;39:1-5.
39. Shechter Y, Karlish SJ. Insulin-like stimulation of glucose oxidation in rat adipocytes by vanadyl (IV) ions. Nature 1980;284:556-8.
40. Shechter Y, Li J, Meyerovitch J, Gefel D, Bruck R, Elberg G, et al. Insulin-like actions of vanadate are mediated in an insulin-receptor-independent manner via non-receptor protein tyrosine kinases and protein phosphotyrosine phosphatases. Mol Cell Biochem 1995;153:39-47.
41. Shisheva A, Shechter Y. A cytosolic protein tyrosine kinase in rat adipocytes. FEBS Lett 1992;300:93-6.
42. Shisheva A, Shechter Y. Role of cytosolic tyrosine kinase in mediating insulin-like actions of vanadate in rat adipocytes. J Biol Chem 1993;268:6463-9.
43. Soares SS, Martins H, Aureliano M. Vanadium distribution following decavanadate administration. Arch Environ Contam Toxicol 2006;50:60-4.
44. Soares SS, Martins H, Duarte RO, Moura JJG, Coucelo J, Gutiérrez-Merino C, et al. Vanadium distribution, lipid peroxidation and oxidative stress markers upon decavanadate in vivo administration. J Inorg Biochem 2007;101:80-8.
45. Tiago T, Aureliano M, Gutierrez-Merino C. Decavanadate binding to a high affinity site near the myosin catalytic centre inhibits F-actin-stimulated myosin ATPase activity. Biochemistry 2004;43:5551-61.
46. Yang XG, Yang XD, Yuan L, Wang K, Crans DC. The permeability and cytotoxicity of insulin-mimetic vanadium compounds. Pharm Res 2004;21:1026-33.